Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1/2 2Phase 4 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Rituximab 4Cyclophosphamide 4pirtobrutinib 3fludarabine 2Chlorambucil 2venetoclax 1ofatumumab 1idelalisib 1ibrutinib 1fludarabine phosphate 1acalabrutinib 1Valganciclovir 1Thiotepa 1Sirolimus 1Radiotherapy 1Prednisone 1Pneumococcal Vaccines 1Pentostatin 1Filgrastim 1Everolimus 1Biopsy, Needle 1Bendamustine Hydrochloride 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Lymphocytic, Chronic, B-Cell × Pentostatin × Clear all
NCT00131313 2005-08-18

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

East Valley Hematology and Oncology Medical Group

Phase 4 Unknown
180 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡